Tissue Oxygenation, Lactate, and Markers of Oxygen Debt

Oxygen transport becomes clinically useful when it explains what tissues can do with the oxygen they receive. Chapters 4 and 34 developed delivery, consumption, and extraction; Chapter 15 examined their distribution through the microcirculation. This chapter connects those mechanisms to lactate and bedside perfusion findings. Each measurement reveals part of the process. Their agreement strengthens an explanation, while disagreement often identifies the next physiological question.

37.1 Tissue Oxygenation Requires More Than an Adequate Arterial Supply

Oxygen must reach an organ in flowing blood, pass from red cells into the tissue, and enter functioning oxidative pathways. Arterial oxygen content determines the oxygen carried per unit of blood. Regional blood flow determines how much arrives per minute. Capillary distribution and diffusion determine which cells can access it. Cellular metabolism determines how much is used and how much energy that use produces.

These steps explain why arterial saturation can remain satisfactory during circulatory shock. The blood entering the systemic circulation may carry oxygen normally, while insufficient flow reaches a threatened organ. Conversely, a satisfactory cardiac output can coexist with markedly unequal microvascular flow. Averages across the circulation can conceal poorly perfused regions beside well-perfused ones. De Backer and colleagues demonstrated reduced perfusion and heterogeneous flow in the sublingual microcirculation of patients with sepsis; the abnormalities were more severe among nonsurvivors. This was observational evidence from one accessible vascular bed, rather than a direct survey of every organ. 1

Tissue oxygen tension and oxygen use also describe different things. A tissue can contain oxygen while using less because energy demand has fallen or oxidative machinery is impaired. Low tissue oxygen tension can reflect restricted supply, increased consumption, or diffusion distance. Neither finding alone identifies the complete mechanism.

The bedside task is therefore to connect transport to function. Altered consciousness, reduced urine output, skin perfusion, biochemical changes, and organ-specific findings supply complementary information. A regional ischemic emergency may produce little change in a whole-body marker, especially early in its course.

37.2 Oxygen Debt Is an Accumulated Experimental Shortfall

When oxygen supply becomes inadequate, tissues initially increase extraction to maintain consumption. If compensation is exhausted, actual oxygen uptake can fall below the amount that would otherwise support metabolic requirements. The shortfall accumulated over time is commonly called oxygen debt in shock physiology.

Classic hemorrhage experiments compared measured oxygen consumption during hypotension with a preshock reference. Crowell and Smith continuously accumulated this difference in dogs. Subsequent experimental work related oxygen debt and metabolic abnormalities to the severity and outcome of controlled hemorrhagic shock. These experiments established a useful relationship within their models; they did not establish a universal conversion from human blood lactate to milliliters of missing oxygen. 2 3

An illustrative calculation shows the dimensions. Suppose the reference consumption is 250 mL O₂/min, while actual consumption remains 180 mL O₂/min for 20 minutes. The missing rate is 70 mL O₂/min. Multiplying by the duration gives an accumulated shortfall of 1,400 mL O₂. If the mismatch changes, its changing magnitude must be integrated over time.

The difficult quantity in a patient is the counterfactual requirement: what oxygen consumption would have been without supply limitation. Sedation, temperature, muscle activity, nutrition, and illness change demand. A low measured consumption does not automatically establish unmet demand. Increased oxygen uptake during recovery can include thermogenesis and repair as well as restoration of depleted energy stores.

A lactate concentration, base deficit, or venous saturation cannot supply the missing consumption history. Such measurements can signal risk and support a diagnosis of impaired perfusion. They do not measure accumulated oxygen debt directly or prescribe a quantity of fluid, blood, or oxygen needed to repay it.

37.3 Lactate Formation Maintains Cytosolic Redox Balance

Glycolysis converts glucose to pyruvate while generating ATP and reducing the electron carrier NAD⁺ to NADH. Continued glycolysis requires regeneration of NAD⁺. Lactate dehydrogenase, abbreviated LDH, connects this requirement to pyruvate metabolism through a reversible reaction.

In the lactate-forming direction, pyruvate accepts reducing equivalents from NADH. Regenerated NAD⁺ can support further glycolytic reactions. LDH does not itself make ATP; it permits continued glycolytic ATP production by maintaining the required redox partner. Lactate can subsequently be converted back to pyruvate and enter oxidative metabolism or glucose synthesis.

Oxygen limitation can favor this pathway because mitochondrial oxidation and the transfer of cytosolic reducing equivalents become constrained. However, lactate formation does not require the absence of oxygen. Rapid glycolytic flux can generate pyruvate and NADH faster than their alternative pathways handle them even while oxidative phosphorylation continues. Cells without mitochondria also depend on glycolysis despite exposure to oxygenated blood.

The lactate–pyruvate relationship is connected to the cytosolic NADH/NAD⁺ state through the LDH equilibrium. Classic freeze-clamped liver experiments developed this relationship while distinguishing cytoplasmic and mitochondrial redox pools. Its application depends on equilibrium, pH, and compartment assumptions. 4

A blood lactate value therefore cannot be read as a mitochondrial oxygen meter. Even a blood lactate-to-pyruvate ratio mixes the contributions of several tissues and requires careful sampling and interpretation. It does not directly measure the free NADH/NAD⁺ ratio inside the threatened organ. Likewise, elevated lactate and acidemia often coexist, but lactate concentration alone does not quantify the processes producing or removing hydrogen ions.

37.4 Adrenergic Stimulation Can Increase Aerobic Lactate Production

Stress changes both energy demand and the rate at which substrates move through metabolic pathways. Adrenergic stimulation can accelerate glycogen breakdown and glycolysis. β₂-mediated stimulation of the sodium–potassium ATPase increases ATP use, and locally coupled glycolysis can help supply that ATP. Pyruvate generation and lactate formation can consequently increase while the tissue continues consuming oxygen.

James and colleagues linked epinephrine-stimulated lactate production to sodium–potassium pump activity in oxygenated rat skeletal muscle. This supports an experimental mechanism of aerobic glycolysis, without establishing its contribution to circulating lactate in human septic shock. 5

This distinction matters when lactate rises after an adrenergic change. An epinephrine infusion, inhaled β₂ agonists, agitation, shivering, or sustained muscular activity can increase glycolytic flux. A patient receiving escalating cardiovascular support may simultaneously have impaired perfusion, increased adrenergic lactate generation, and reduced disposal. The explanations are compatible rather than mutually exclusive.

Consider two patients with the same lactate concentration. One has active hemorrhage, cool skin, and low cardiac output. The other develops a modest lactate rise after intensified β₂-agonist treatment while breathing and peripheral perfusion improve. The concentration has the same units in both, but its relationship to oxygen limitation differs. Those examples are illustrations of mechanisms, not diagnoses established by their patterns alone.

Recognizing aerobic production does not make persistent hyperlactatemia harmless. Stress intensity and illness severity can generate a prognostic association even when lactate is not the mediator of injury. The necessary next step is to determine whether perfusion has improved and which metabolic processes remain active.

37.5 Blood Concentration Reflects Appearance, Disposal, and Distribution

The circulating lactate pool receives lactate released from tissues and loses lactate taken up for metabolism. Its concentration depends on these opposing rates and on distribution. A simplified mass balance makes the distinction explicit. Here C is concentration in mmol/L, V is an effective distribution volume in liters, and the two rates are measured in mmol/min.

Amount is approximated by C × V within this simplified pool. Thus concentration can rise when appearance increases, disposal decreases, or both occur. Changes in distribution further complicate interpretation during rapidly changing illness. Intracellular production and reutilization can also occur without all that lactate appearing in blood.

The liver converts lactate to glucose and oxidizes lactate-derived substrate. The kidneys also metabolize lactate, including through gluconeogenesis; their contribution is not simply urinary excretion. Isotope and renal-balance measurements in healthy postabsorptive humans demonstrated substantial renal lactate uptake. Those findings establish an important disposal pathway without assigning the same fractional contribution to a patient with shock. 6 Heart and skeletal muscle can also use circulating lactate as oxidative fuel.

Organ dysfunction can therefore prolong hyperlactatemia without a continuing increase in production. Hepatic blood flow, cellular function, and substrate handling all affect hepatic disposal. Kidney dysfunction can alter renal metabolism, while shock can change several pathways together. Levraut and colleagues found impaired lactate utilization in stable septic patients with mild hyperlactatemia, illustrating why a production-only explanation is insufficient. 7

True metabolic clearance describes removal relative to concentration, commonly expressed as a volume per unit time under defined conditions. Measuring it requires information about lactate kinetics, often from tracer or controlled-infusion methods. Two routine concentrations alone cannot separate disappearance from continuing appearance.

37.6 A Percentage Decrement Is a Concentration Trend, Not Measured Clearance

Serial lactate measurements show whether the circulating concentration is rising or falling over a specified interval. The term “lactate clearance” is often used clinically for the percentage fall. That convention should not obscure what was actually measured: a change in concentration rather than physiological clearance.

Suppose an illustrative patient has a lactate of 6.0 mmol/L initially and 4.5 mmol/L two hours later. The initial value supplies the denominator because the question is how much of the starting concentration has disappeared from the measured concentration. The absolute fall is 1.5 mmol/L.

The calculation is [(6.0 − 4.5) ÷ 6.0] × 100 = 25%. Across two hours, the average concentration decline is 0.75 mmol/L per hour. Neither result means that 25% of lactate production has stopped or that the liver removed a measured amount of lactate. Production and disposal may both have increased while disposal exceeded appearance.

Timing matters. A 25% fall over two hours differs from the same fall over twelve hours. The starting value matters too: an identical absolute reduction produces a different percentage from a different baseline. A later plateau may represent continuing production balanced by disposal, changing distribution, or several mechanisms at once.

Compare samples obtained and processed consistently. Record whether arterial or venous blood was used, the interval, and intervening treatments. Avoid contamination from an infusion line and avoid delayed processing that permits ongoing cellular metabolism in the sample. An unexpected result merits verification while clinically evident deterioration is addressed.

The useful statement is therefore specific: “Lactate fell from 6.0 to 4.5 mmol/L over two hours.” Interpretation then asks whether the fall accompanies improved perfusion and organ function. It cannot be converted into a measured repayment of oxygen debt.

37.7 Hyperlactatemia Requires a Mechanism Before a Treatment

Reduced oxygen delivery is a central explanation when lactate rises during hemorrhage, severe low-flow states, or marked arterial hypoxemia. Regional ischemia can generate lactate even when global transport appears satisfactory. In these situations, urgent assessment must locate and correct the supply problem rather than wait for a laboratory threshold.

Other mechanisms alter the same circulating pool. Adrenergic acceleration and seizures can increase production. Liver dysfunction can reduce disposal. Some drugs and toxins interfere with oxidative metabolism or substrate handling; their effects may be amplified when elimination is impaired. Thiamine deficiency can restrict pyruvate oxidation. Malignant or inflammatory metabolic activity can also increase lactate turnover. More than one mechanism may operate in the same patient.

This framework is more useful than treating an etiological label as proof that oxygen supply is either adequate or inadequate. A patient with liver disease can still develop hemorrhagic shock. A patient receiving epinephrine can still have bowel ischemia. Conversely, persistent lactate after correction of a low-flow state need not mean that additional flow will improve metabolism.

Fluid is relevant when a circulatory deficit can be improved by increasing effective preload and when the added volume is tolerable. Lactate alone establishes neither condition. Additional volume may fail to increase cardiac output and may worsen congestion or pulmonary edema. An inotrope or transfusion similarly requires an explanation of the transport limitation and separate evidence about likely benefit and harm.

Look for the mechanism through the history, examination, hemodynamics, organ function, medication exposure, and trajectory. A normal systemic lactate cannot exclude a small or poorly washed-out ischemic region. An elevated value cannot establish fluid responsiveness. Both errors arise from assigning one concentration a diagnostic task beyond its physiology.

37.8 Capillary Refill and Mottling Add Regional Perfusion Information

Capillary refill time, or CRT, measures how long skin color takes to return after a standardized blanching maneuver. It reflects the refilling behavior of a superficial vascular bed. Changes in skin blood flow and vascular tone can alter it quickly, making repeated examination useful during a changing circulation.

Standardization makes change more interpretable. Use the same anatomical site, consistent blanching pressure and duration, and a timer under suitable lighting. The ANDROMEDA protocols used a defined finger technique rather than an unspecified impression that refill looked slow. Temperature, pigmentation, peripheral vascular disease, and the observer’s ability to identify return of color can affect assessment. A measurement that cannot be assessed reliably should not acquire false precision because it is recorded in seconds. 13 15

Mottling describes patchy skin discoloration associated with disturbed cutaneous perfusion. Ait-Oufella and colleagues developed a score based on its extent around the knee and found associations with mortality in septic shock. This established prognostic information in an observational cohort, rather than proof that an intervention that removes mottling improves survival. Visual grading also depends on skin characteristics and examination conditions. 8

Skin findings and lactate operate on different processes and timescales. CRT can improve while lactate remains elevated because metabolic disposal takes time or adrenergic production continues. Persistent abnormal CRT despite a falling lactate may expose an unresolved peripheral circulatory problem. Neither pattern should be forced into agreement by assuming one measurement must be wrong.

The skin is accessible, but it is not every organ. Improved refill cannot rule out mesenteric ischemia, and sublingual microvascular imaging cannot automatically describe renal capillary flow. Organ-specific symptoms and function retain their own diagnostic weight.

37.9 Venous Oxygen and Carbon Dioxide Describe Different Balances

Venous oxygen saturation reflects oxygen remaining after tissue extraction. With arterial content and demand otherwise similar, low flow requires greater extraction and tends to lower venous saturation. Increased demand or reduced hemoglobin can produce a similar direction of change. A low value therefore identifies a balance that requires explanation rather than a single diagnosis.

Mixed venous saturation, SvO₂, samples pulmonary arterial blood after systemic venous mixing. Central venous saturation, ScvO₂, represents the mixture reaching the catheter tip, usually in the superior central circulation. Their relationship changes with regional flow and extraction. Chawla and colleagues demonstrated clinically important disagreement between paired measurements; the values should not be substituted as though they were identical. 9

A high value can reflect abundant flow relative to demand, reduced metabolic demand, impaired extraction, or heterogeneous distribution. Venous blood from adequately perfused regions can dilute the signal from a threatened region. Thus a high ScvO₂ does not prove that every cell has received enough oxygen or establish mitochondrial failure.

The venous-to-arterial carbon dioxide pressure difference asks a related but distinct question. It subtracts arterial PCO₂ from venous PCO₂, using samples from specified sites obtained close together in time. For example, a central venous PCO₂ of 48 mm Hg and arterial PCO₂ of 40 mm Hg give a gap of 8 mm Hg. The result is a pressure difference, not a directly measured tissue CO₂ production rate.

Reduced blood flow can impair CO₂ washout and widen the gap. In an isolated canine hindlimb experiment, lowering flow and lowering arterial oxygen content produced different gap behavior despite oxygen limitation, demonstrating that dysoxia alone does not necessarily widen it. 10 CO₂ production, acid–base conditions, hemoglobin oxygenation, and the nonlinear relation between CO₂ content and pressure further affect interpretation. The gap can support a flow hypothesis; it cannot independently diagnose oxygen debt or select a universal resuscitation endpoint.

37.10 Cellular Dysfunction Is Plausible Without Being Diagnosed by Lactate

Oxygen reaching a cell must still participate in mitochondrial electron transport and ATP synthesis. Inflammation, oxidative injury, altered enzyme activity, and changes in substrate availability can interfere with this machinery. Reduced oxidative ATP production is therefore mechanistically different from insufficient vascular delivery, although both can occur together.

Human evidence supports a role for altered bioenergetics in sepsis but requires careful scaling. Brealey and colleagues examined skeletal-muscle biopsies from 28 critically ill septic patients and control patients. Respiratory-chain abnormalities and lower ATP concentrations were associated with illness severity and outcome. The study linked measured biochemical findings in sampled muscle to clinical observations; it did not show that every organ had the same defect or that this mechanism accounted for each patient’s lactate. 11

Reduced oxygen consumption also has several meanings. Sedation and reduced muscle activity can lower demand appropriately. Cells may reduce energetically expensive functions during stress. Loss of viable tissue or impaired metabolic machinery can lower use pathologically. A whole-body consumption measurement cannot distinguish these possibilities without context.

This matters when high venous saturation, organ dysfunction, and elevated lactate coexist. The combination is compatible with impaired extraction or metabolism, but it also permits altered regional distribution, adrenergic production, and reduced disposal. Naming the pattern “cytopathic hypoxia” does not establish which mechanism is present.

Mechanistic plausibility can guide investigation and generate hypotheses for therapy. It cannot establish that increasing oxygen delivery will overcome an intracellular block, or that a proposed metabolic treatment improves outcomes. Those conclusions require intervention evidence in an appropriate population.

37.11 Resuscitation Trials Test Strategies Rather Than the Meaning of One Marker

Serial markers can improve a clinical strategy without becoming specific tests of hypoxia. Trials evaluate the full sequence of assessment, treatment decisions, reassessment, and stopping rules. Their findings cannot automatically be attributed to the isolated measurement or to the biological removal of lactate.

In Jansen and colleagues’ 2010 trial, a lactate-guided strategy was compared with care in which clinicians were blinded to subsequent lactate values. Unadjusted hospital mortality was lower numerically but did not meet conventional statistical significance; adjustment for predefined risk factors favored the intervention. Lactate concentrations did not differ significantly between groups. This distinction matters when describing the trial as evidence supporting a resuscitation strategy rather than an unqualified demonstration of mortality reduction from lactate normalization. 12

The 2019 ANDROMEDA-SHOCK trial compared CRT-targeted with lactate-targeted resuscitation in 424 patients with septic shock. Mortality at 28 days was 34.9% versus 43.4%, respectively; the hazard ratio was 0.75, with 95% confidence interval 0.55–1.02 and P = .06. The primary comparison did not establish a survival benefit, and the result did not establish equivalence. 13

ANDROMEDA-SHOCK-2, published in 2025, compared a personalized CRT-targeted hemodynamic protocol with usual care. Its hierarchical composite of mortality, duration of vital support, and hospital stay favored the protocol, with a win ratio of 1.16 and 95% confidence interval 1.02–1.33. The win ratio summarizes favorable versus unfavorable pairwise comparisons of the ordered outcomes; it is not a relative mortality reduction. Mortality alone at 28 days was similar, 26.5% versus 26.6%. The protocol incorporated hemodynamic assessment, fluid-responsiveness testing, echocardiography, and selected treatment trials; its effect cannot be isolated to CRT measurement. 14

The 2026 Surviving Sepsis Campaign conditionally suggests serial lactate measurements to guide resuscitation in adults with elevated lactate and sepsis or with septic shock. It also conditionally suggests CRT as an adjunct to other perfusion measures; both recommendations have low-certainty evidence. Its lactate remark calls for individualized fluid after the initial bolus and assessment of decrement, rather than continuing fluid until lactate normalizes. 15

These findings support structured reassessment. They do not turn a trial-specific lactate decrement or CRT cutoff into a universal metabolic requirement for every critically ill patient.

37.12 Integrating a Changing Pattern at the Bedside

Consider an illustrative patient with septic shock. Initially, lactate is 6.0 mmol/L, finger refill takes five seconds under a standardized examination, urine output is low, and the patient is cool. Hemoglobin and arterial saturation must be assessed alongside flow; satisfactory saturation alone would not explain away these findings.

After initial treatment, cardiac output and arterial pressure improve, and refill shortens to two seconds. Two hours after the first sample, lactate is 4.5 mmol/L. The absolute fall is 1.5 mmol/L and the percentage decrement is 25%. The combination supports improvement, but neither value measures how much oxygen debt has been repaid. Low urine output may persist because renal recovery and hormonal responses follow a different timescale.

Suppose ScvO₂ is now 80%, while the central venous-to-arterial CO₂ gap has narrowed. These findings support a changed global flow–extraction relationship. They do not exclude a regional problem. The next examination still addresses abdominal findings, limb perfusion, mentation, congestion, and the trajectory of organ dysfunction.

If lactate then plateaus, review its sources and disposal. Continuing adrenergic stimulation, hepatic dysfunction, and an unresolved ischemic process have different implications. Determine whether further preload augmentation could increase useful flow and whether added fluid is tolerable. The plateau itself answers neither question.

Conversely, if lactate falls while the abdomen becomes distended and painful, the favorable systemic trend cannot dismiss the new regional signal. If refill worsens while lactate remains unchanged, reassess the circulation promptly rather than waiting for biochemical confirmation.

The purpose of combining markers is to refine a causal explanation that can be challenged by subsequent observations. The most useful endpoint is an improving patient with an understood physiological trajectory, rather than forced agreement between measurements that represent different processes.

References

1. De Backer D, Creteur J, Preiser JC, Dubois MJ, Vincent JL. Microvascular blood flow is altered in patients with sepsis. Am J Respir Crit Care Med. 2002;166(1):98–104. doi:10.1164/rccm.200109-016OC

2. Crowell JW, Smith EE. Oxygen deficit and irreversible hemorrhagic shock. Am J Physiol. 1964;206:313–316. doi:10.1152/ajplegacy.1964.206.2.313

3. Dunham CM, Siegel JH, Weireter L, et al. Oxygen debt and metabolic acidemia as quantitative predictors of mortality and the severity of the ischemic insult in hemorrhagic shock. Crit Care Med. 1991;19(2):231–243. doi:10.1097/00003246-199102000-00020

4. Williamson DH, Lund P, Krebs HA. The redox state of free nicotinamide-adenine dinucleotide in the cytoplasm and mitochondria of rat liver. Biochem J. 1967;103(2):514–527. doi:10.1042/bj1030514

5. James JH, Wagner KR, King JK, et al. Stimulation of both aerobic glycolysis and Na+-K+-ATPase activity in skeletal muscle by epinephrine or amylin. Am J Physiol. 1999;277:E176–E186. Original experimental study.

6. Meyer C, Stumvoll M, Dostou J, Welle S, Haymond M, Gerich J. Renal substrate exchange and gluconeogenesis in normal postabsorptive humans. Am J Physiol Endocrinol Metab. 2002;282(2):E428–E434. doi:10.1152/ajpendo.00116.2001

7. Levraut J, Ciebiera JP, Chave S, et al. Mild hyperlactatemia in stable septic patients is due to impaired lactate clearance rather than overproduction. Am J Respir Crit Care Med. 1998;157(4 Pt 1):1021–1026. doi:10.1164/ajrccm.157.4.9705037

8. Ait-Oufella H, Lemoinne S, Boelle PY, et al. Mottling score predicts survival in septic shock. Intensive Care Med. 2011;37(5):801–807. doi:10.1007/s00134-011-2163-y

9. Chawla LS, Zia H, Gutierrez G, Katz NM, Seneff MG, Shah M. Lack of equivalence between central and mixed venous oxygen saturation. Chest. 2004;126(6):1891–1896. doi:10.1378/chest.126.6.1891

10. Vallet B, Teboul JL, Cain S, Curtis S. Venoarterial CO₂ difference during regional ischemic or hypoxic hypoxia. J Appl Physiol. 2000;89(4):1317–1321. doi:10.1152/jappl.2000.89.4.1317

11. Brealey D, Brand M, Hargreaves I, et al. Association between mitochondrial dysfunction and severity and outcome of septic shock. Lancet. 2002;360(9328):219–223. doi:10.1016/S0140-6736(02)09459-X

12. Jansen TC, van Bommel J, Schoonderbeek FJ, et al.; LACTATE Study Group. Early lactate-guided therapy in intensive care unit patients: a multicenter, open-label, randomized controlled trial. Am J Respir Crit Care Med. 2010;182(6):752–761. doi:10.1164/rccm.200912-1918OC

13. Hernández G, Ospina-Tascón GA, Damiani LP, et al.; ANDROMEDA-SHOCK Investigators. Effect of a resuscitation strategy targeting peripheral perfusion status vs serum lactate levels on 28-day mortality among patients with septic shock: the ANDROMEDA-SHOCK randomized clinical trial. JAMA. 2019;321(7):654–664. doi:10.1001/jama.2019.0071

14. Hernández G, Ospina-Tascón GA, Kattan E, et al.; ANDROMEDA-SHOCK-2 Investigators. Personalized hemodynamic resuscitation targeting capillary refill time in early septic shock: the ANDROMEDA-SHOCK-2 randomized clinical trial. JAMA. 2025;334(22):1988–1999. doi:10.1001/jama.2025.20402

15. Society of Critical Care Medicine and European Society of Intensive Care Medicine. Surviving Sepsis Campaign: international guidelines for management of sepsis and septic shock 2026. Official recommendations.